The Experimental treatment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)

Purpose of study:  To determine if Nuedexta exerts a palliative effect on speech, swallowing and salivation in patients with ALS.

Principal Investigator:  Dr. Kimberly Goslin
Contact:  Providence ALS Research Nurse at 503 962-1171

Sponsor:  ALS Association (ALSA) and the Northeast ALS Consortium (NEALS)